Idea or Concept
SBA Defends 8(a) Program Reforms Amid Constitutional Challenges and Increased Scrutiny in 2026
8(a) program; SBA; business practices; constitutional challenges; Trump Administration; social disadvantage
Sarepta Therapeutics Reports Positive Three-Year EMBARK Data for Elevidys in Duchenne Amid Past Safety Concerns
Sarepta; Elevidys; Duchenne muscular dystrophy; EMBARK trial; three-year data; gene therapy; patient deaths
No Recent News on BetterHelp’s Quiet AI Expansion; Focus Remains on Insurance Growth
Teladoc; BetterHelp; insurance expansion; UpLift acquisition; mental health; revenue decline
Lean Derisking: Taking Your Proof of Concept to the Clinic Webinar Announced
Lean Derisking; Proof of Concept; Clinical Development; Webinar; Applied Pharma; Sir Michael Houghton
Vaccine Investors Stay Silent Amid Trump Administration’s Childhood Vaccine Schedule Cuts
Trump vaccine schedule; RFK Jr.; CDC recommendations; childhood vaccines; vaccine overhaul
US Commits $480-487 Million in Health Funding to Ivory Coast Under ‘America First’ Health Strategy
US Ivory Coast health agreement; America First health deals; $487 million funding; HIV malaria tuberculosis; global health security
Biogen Issues Statement Mourning Co-Founder Charles Weissmann’s Passing
Biogen; Charles Weissmann; co-founder; passing; statement; condolences; biotechnology
Coloplast announces changes to Executive Leadership Team
Coloplast; Executive Leadership Team; ELT changes; Interventional Urology; People & Culture; Kevin Hardage; Tommy Johns; leadership transition; management changes
Biopharma’s Winners and Losers of 2025 – Endpoints News recap
Endpoints News; winners and losers; 2025; biopharma; Post-Hoc Live; Kyle LaHucik; year in review; biotech; pharma; stock movers
No public results for “Take the Biopharma Sentiment Index” Q1 2026 yet
Biopharma Sentiment Index; Q1 2026; biopharma executives; life sciences sentiment; 2026 outlook; M&A activity; AI in biopharma; geopolitical risk; survey data